Aridis Pharmaceuticals, Inc. Quarterly Preferred Stock, Shares Authorized from Q4 2019 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Summary
Aridis Pharmaceuticals, Inc. quarterly Preferred Stock, Shares Authorized history and growth rate from Q4 2019 to Q3 2023.
  • Aridis Pharmaceuticals, Inc. Preferred Stock, Shares Authorized for the quarter ending September 30, 2023 was 60M shares, unchanged year-over-year.
Preferred Stock, Shares Authorized, Quarterly (shares)
Preferred Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 60M 0 0% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 60M 0 0% Jun 30, 2023 10-Q 2023-09-14
Q1 2023 60M 0 0% Mar 31, 2023 10-Q 2023-06-08
Q4 2022 60M 0 0% Dec 31, 2022 10-Q 2023-11-06
Q3 2022 60M 0 0% Sep 30, 2022 10-Q 2022-11-21
Q2 2022 60M 0 0% Jun 30, 2022 10-Q 2022-08-16
Q1 2022 60M 0 0% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 60M 0 0% Dec 31, 2021 10-K 2023-05-22
Q3 2021 60M 0 0% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 60M 0 0% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 60M 0 0% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 60M 0 0% Dec 31, 2020 10-Q 2021-11-10
Q3 2020 60M Sep 30, 2020 10-Q 2020-11-23
Q2 2020 60M Jun 30, 2020 10-Q 2020-08-11
Q1 2020 60M Mar 31, 2020 10-Q 2020-05-12
Q4 2019 60M Dec 31, 2019 10-K 2021-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.